RU2007124609A - Сопряженный с g-белком рецептор - Google Patents

Сопряженный с g-белком рецептор Download PDF

Info

Publication number
RU2007124609A
RU2007124609A RU2007124609/15A RU2007124609A RU2007124609A RU 2007124609 A RU2007124609 A RU 2007124609A RU 2007124609/15 A RU2007124609/15 A RU 2007124609/15A RU 2007124609 A RU2007124609 A RU 2007124609A RU 2007124609 A RU2007124609 A RU 2007124609A
Authority
RU
Russia
Prior art keywords
seq
gpr39
protein
compound
acid sequence
Prior art date
Application number
RU2007124609/15A
Other languages
English (en)
Russian (ru)
Inventor
Дидерик Виллем Элизабет МУХАРС (BE)
Дидерик Виллем Элизабет МУХАРС
Бенуа Кристиан Жан-Клод МОРО (BE)
Бенуа Кристиан Жан-Клод МОРО
Теофиль Луи Анри ПЕЕТЕРС (BE)
Теофиль Луи Анри ПЕЕТЕРС
Инге Ирма Тереза ДЕПОРТЕРЕ (BE)
Инге Ирма Тереза ДЕПОРТЕРЕ
Бернар КУЛИ (BE)
Бернар КУЛИ
Original Assignee
Янссен Фармацевтика Н.В. (Be)
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. (Be), Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В. (Be)
Publication of RU2007124609A publication Critical patent/RU2007124609A/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2007124609/15A 2004-12-01 2005-11-30 Сопряженный с g-белком рецептор RU2007124609A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106220.9 2004-12-01
EP04106220 2004-12-01

Publications (1)

Publication Number Publication Date
RU2007124609A true RU2007124609A (ru) 2009-01-10

Family

ID=34929976

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007124609/15A RU2007124609A (ru) 2004-12-01 2005-11-30 Сопряженный с g-белком рецептор

Country Status (10)

Country Link
EP (1) EP1820026A1 (ja)
JP (1) JP2008521419A (ja)
KR (1) KR20070086003A (ja)
CN (1) CN101107529A (ja)
AU (1) AU2005311321A1 (ja)
CA (1) CA2587534A1 (ja)
NO (1) NO20073294L (ja)
RU (1) RU2007124609A (ja)
WO (1) WO2006058889A1 (ja)
ZA (1) ZA200704526B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1743944A4 (en) * 2004-04-23 2011-01-05 Takeda Pharmaceutical NEW SCREENING PROCEDURE
JP2009539362A (ja) * 2006-06-08 2009-11-19 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｇタンパク質共役型受容体３９（ｇｐｒ３９）
CN111443209B (zh) * 2020-03-26 2022-12-20 中国中医科学院医学实验中心 一种筛选非激动剂型PPARγ配体的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001257406A1 (en) * 2000-04-26 2001-11-07 Millennium Pharmaceuticals, Inc. Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
WO2002086460A1 (en) * 2001-04-20 2002-10-31 Consensus Pharmaceuticals, Inc. Methods for identifying ligands of g-protein-coupled receptors
US20030232769A1 (en) * 2002-06-17 2003-12-18 Isis Pharmaceuticals Inc. Antisense modulation of G protein-coupled receptor 39 expression
CA2498264A1 (en) * 2002-09-09 2004-05-13 Nura, Inc. G protein coupled receptors and uses thereof
US20040071708A1 (en) * 2002-09-26 2004-04-15 Immusol, Inc. GPR 39 modulators that control cancerous cell growth
NZ540084A (en) * 2002-10-31 2007-08-31 Janssen Pharmaceutica Nv CRH responsive genes in CNS
US20080038247A1 (en) * 2003-05-05 2008-02-14 Bayer Healthcare Ag Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39)

Also Published As

Publication number Publication date
CA2587534A1 (en) 2006-06-08
JP2008521419A (ja) 2008-06-26
CN101107529A (zh) 2008-01-16
AU2005311321A1 (en) 2006-06-08
NO20073294L (no) 2007-08-29
WO2006058889A1 (en) 2006-06-08
EP1820026A1 (en) 2007-08-22
KR20070086003A (ko) 2007-08-27
ZA200704526B (en) 2008-11-26

Similar Documents

Publication Publication Date Title
Norheim et al. Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training
CN113557431A (zh) 诊断SARS-CoV-2感染的方法和试剂
EP2853898B1 (en) Analysis of myostatin in serum
JP2004513608A5 (ja)
CN106959367A (zh) 用于测定样本中的待测定成分的方法和试剂盒
RU2012148125A (ru) Биомаркеры на основе мультиракового ассоциированного с инвазией механизма
RU2009135270A (ru) Способы выявления воспалительного заболевания кишечника
JP2010521655A5 (ja)
CN1623000A (zh) 多肽的定量分析方法
Bruno et al. Discrimination of recombinant from natural human growth hormone using DNA aptamers
JP2010522541A5 (ja)
Wintgens et al. Plasma myostatin measured by a competitive ELISA using a highly specific antiserum
US20220098248A1 (en) Unstructured non-repetitive polypeptides having lcst behavior
RU2007124609A (ru) Сопряженный с g-белком рецептор
CN110139663B (zh) 检测抗瘦素中和抗体的方法
JP2005516605A5 (ja)
JP4734619B2 (ja) 新規ストレスバイオマーカー及びその用途
CA2450581A1 (en) Cardiovascular safety assay
Zhou et al. The amino and carboxyl domains of the infectious bronchitis virus nucleocapsid protein interact with 3′ genomic RNA
JP2008547006A5 (ja)
CN101918432A (zh) 与风湿性关节炎自身抗体发生免疫反应的合成肽
DK2677319T3 (en) An antibody for the detection of neurotoxic amino acids associated with neurological disorders.
JP5284637B2 (ja) 細胞タンパク質の発現を変化させる薬剤を同定するためのハイスループットアッセイ系および方法
Cherepanov et al. An improved sample extraction method reveals that plasma receptor for advanced glycation end-products (RAGE) modulates circulating free oxytocin in mice
US20230417742A1 (en) Improved assays to detect nucleosome modifications using antibody-targeted enzyme digestion

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20100310